Pandemic-Linked Decline in Cancer Screening Persisted Into 2022
The decrease in cancer screening seen during the early stage of the COVID-19 pandemic persisted into 2022.
Stay updated with breaking news from Christopher Doan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The decrease in cancer screening seen during the early stage of the COVID-19 pandemic persisted into 2022.
MONDAY, Feb. 6, 2023 (HealthDay News) -- The decrease in cancer screening seen during the early stage of the COVID-19 pandemic persisted into 2022, according to a study published online Feb. 3 in JAMA Network Open. Christopher Doan, from the University of Texas Medical Branch in Galveston, and colleagues examined the observed versus expected mammography
Researchers at the University of Texas found that cancer screenings decreased when Covid infection rates were higher, but rose when they started to fall.
Tens of thousands of Americans have missed screenings for breast and lung cancer in the two years since the start of the Covid pandemic, another study found.
A game-changing development in Chinatown will soon expand. The developer behind Bellaire Food Street will soon begin work on a second phase of the dining-foc